Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001437749-25-036354
Filing Date
2025-11-25
Accepted
2025-11-25 17:24:49
Documents
17

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A nby20251121_s3a.htm   iXBRL S-3/A 406159
2 EXHIBIT 5.1 ex_893262.htm EX-5.1 19684
3 EXHIBIT 23.1 ex_892061.htm EX-23.1 2582
8 logolg.jpg GRAPHIC 11348
9 randg.jpg GRAPHIC 12912
  Complete submission text file 0001437749-25-036354.txt   668706

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nby-20251231.xsd EX-101.SCH 5416
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20251231_def.xml EX-101.DEF 12106
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20251231_lab.xml EX-101.LAB 25968
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20251231_pre.xml EX-101.PRE 12385
19 EXTRACTED XBRL INSTANCE DOCUMENT nby20251121_s3a_htm.xml XML 2616
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-290712 | Film No.: 251522721
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)